# Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma

> **NCT03413436** · PHASE4 · COMPLETED · sponsor: **Henan Cancer Hospital** · enrollment: 733 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** Lobaplatin
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT03413436
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-31
- **Primary completion:** 2018-02-21
- **Final completion:** 2018-02-21
- **Target enrollment:** 733 (ACTUAL)
- **Last updated:** 2020-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03413436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03413436, "Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03413436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*